μ-Opioid receptor-knockout mice: The role of μ-opioid receptor in gastrointestinal transit

Molecular Brain Research

Volumn 56, Issue 1-2, 1998, Pages 281-283

  Roy, Sabita ^a   Liu, Hsien Ching ^a   Loh, Horace H ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Opioid receptor; Gastrointestinal motility; Knockout; Morphine

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; DELTA OPIATE RECEPTOR; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; KAPPA OPIATE RECEPTOR; MORPHINE; MU OPIATE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GASTROINTESTINAL TRANSIT; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANIMALS; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALINS; GASTROINTESTINAL TRANSIT; INJECTIONS, INTRAVENTRICULAR; INJECTIONS, SUBCUTANEOUS; MALE; MICE; MICE, KNOCKOUT; MORPHINE; RECEPTORS, OPIOID, MU;

ANIMALIA;

EID: 0032078392     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(98)00051-5     Document Type: Article

References (20)

1. Broccardo M., Improta G. Antidiarrheal and colonic antipropulsive effects of spinal and supraspinal administration of the natural δ-opioid receptor agonist, [D-Ala2] deltorphin II, in the rat. Eur. J. Pharmacol. 218:1992;69-73.
2. Chamouard P., Rohr S., Meyer C., Baumann R., Angel F. δ-opioid receptor agonists inhibit neuromuscular transmission in human colon. Eur. J. Pharmacol. 262:1994;33-39.
3. Chen Y.A., Mestek A., Liu J., Hurley J.A., Yu L. Molecular cloning and functional expression of a μ-opioid receptor from rat brain. Mol. Pharmacol. 44:1993;8-12.
4. Evans C.J., Keith D.E., Morrison H., Magendzo K., Edwards R.H. Cloning of δ-opioid receptor by functional expression. Science. 258:1992;1952-1955.
5. Haley T.J., McCormick W.G. Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse. Br. J. Pharmacol. Chemother. 12:1957;12-15.
6. B.F. Hogan, F. Constantini, E. Lacy. Manipulating the mouse embryos. A. Lab Manual (1986), Cold Spring Harbor Laboratory, New York.
7. Kieffer B.L., Before K., Caveriuax-Ruff C., Hirth C.G. The δ-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc. Natl. Acad. Sci. U.S.A. 89:1992;12048-12052.
8. Loh H.H., Smith A.P. Molecular characterization of opioid receptors. Ann. Rev. Pharmacol. Toxicol. 30:1989;123-147.
9. H.H. Loh, H.C. Liu, A. Cavalli, W. Yang, Y.F. Che, L.N. Wei. μ-Opioid receptor knockout in mice: effects on ligand induced analgesia and morphine lethality. Mol. Brain Res. (1998) in press.
10. Matthes H.W.D., Maldonado R., Simonin F., Valverde O., Slowe S., Kitchen I., Befort K., Dierich A., Le Meur M., Dolles P., Tzavara E., Hanoune J., Roques B.P., Kieffer B.L. Loss of morphine induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid receptor gene. Nature. 383:1996;819-823.
11. Pasternak G.W. Pharmacological mechanisms of opioid analgesics. Clin. Neuropharmacol. 16:1993;1-18. [Review].
12. Pol O., Planas E., Puig M.M. Peripheral effects of naloxone in mice with acute diarrhea associated with intestinal inflammation. J. Pharmacol. Exp. Ther. 272:1995;1271-1276.
13. Puig M.M., Pol O., Warner W. Interaction of morphine and clonidine on gastrointestinal transit in mice. Anesthesiology. 85:1996;1403-1412.
14. Ramabadran K., Bansinath M., Turndorf H., Puig M.M. Stereospecific inhibition of gastrointestinal transit by κ-opioid receptor. Eur. J. Pharmacol. 155:1988;329-331.
15. Ramabadran K., Bansinath M., Turndorf H., Puig M.M. Hyperglycemia as a factor affecting κ-opiate agonist induced inhibition of the gastrointestinal transit in mice. J. Pharm. Pharmacol. 41:1989;496-498.
16. G.C. Rossi, Y.X. Pan, G.P. Brown, G.W. Pasternak. Antisense mapping the MOR-1 opioid receptor: evidence for alternate splicing and a novel-6b-glucuronide receptor. FEBS Lett. (1995) 192-196.
17. Sora I., Takahashi N., Funadz M., Ujike H., Revay R.S., Donovan D.M., Miner L.L., Uhl G.R. Opioid receptor knockout mice define m receptor roles in endogenous nociceptive responses and morphine induced analgesia. Proc. Natl. Acad. Sci. 94:1997;1544-1549.
18. Tian M., Fan H.E.B., Lai Z., Zhang S., Aronica S., Cooper S., Bigsby R.M., Steinmetz R., Engle S.J., Mestek A., Pollock J.D., Lehman M.N., Jansen H.T., Ying M., Stambrook P.J., Tischfield J.A., Yu L. Altered hematopoiesis, behavior and sexual function in μ-opioid receptor deficient mice. J. Exp. Med. 185:1997;1517-1522.
19. Wang J.B., Imai Y., Eppler C.M., Gregor P., Spivak C.E., Uhl G.R. μ-Opiate receptor: cDNA cloning and expression. Proc. Natl. Acad. Sci. U.S.A. 90:1993;10230-10234.
20. Yasuda K., Raynor K., Kong H., Breder C.D., Takeda J., Reisine T., Bell G.I. Cloning and functional comparison of κ and δ receptors from mouse brain. Proc. Natl. Sci. U.S.A. 90:1993;6736-6740.